NCT04802759 2026-03-16A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerHoffmann-La RochePhase 1/2 Recruiting316 enrolled
NCT03065387 2026-01-12Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS MutationM.D. Anderson Cancer CenterPhase 1 Active not recruiting93 enrolled